Screener
Ovid Therapeutics OVID Q3 2025 earnings
Reported November 12, 2025 · Before market open
Revenue$132.0KBeat by $69.4K
EPS-$0.17Miss by $0.02
Revenue estimate$62.6K
EPS estimate-$0.15
Next report
Nov 11, 2026 (In 1 week)Revenue estimate$31.1K
EPS estimate-$0.08
Versus estimates
Revenue
Q2 2026$733.0KBeat by $711.6KQ4 2025$718.0KBeat by $639.8K
Q3 2025$132.0KBeat by $69.4K
Q2 2025$6.3MBeat by $6.2MQ1 2025$130.0KBeat by $87.5KDiluted EPS
FAQ
- When did Ovid Therapeutics report Q3 2025 earnings?
- Ovid Therapeutics (OVID) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were Ovid Therapeutics's Q3 2025 revenue and EPS?
- Ovid Therapeutics reported revenue of $132.0K and eps of $-0.17 for Q3 2025.
- Did Ovid Therapeutics beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $62.6K by $69.4K. EPS missed the consensus estimate of $-0.15 by $0.02.
- How did Ovid Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 23.7% from $173.0K a year earlier and eps grew 15.0% from $-0.20.
- Where can I find Ovid Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001636651-25-000011) and the 10-Q periodic report (0001636651-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.
